Cargando…
Transcriptomic evidence for tumor‐specific beneficial or adverse effects of TGFβ pathway inhibition on the prognosis of patients with liver cancer
Therapeutic targeting of the transforming growth factor beta (TGFβ) pathway in cancer represents a clinical challenge since TGFβ exhibits either tumor suppressive or tumor promoting properties, depending on the tumor stage. Thus, treatment with galunisertib, a small molecule inhibitor of TGFβ recept...
Autores principales: | Desoteux, Matthis, Maillot, Betty, Bévant, Kevin, Ferlier, Tanguy, Leroux, Raffaële, Angenard, Gaëlle, Louis, Corentin, Sulpice, Laurent, Boudjema, Karim, Coulouarn, Cédric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315808/ https://www.ncbi.nlm.nih.gov/pubmed/37195148 http://dx.doi.org/10.1002/2211-5463.13647 |
Ejemplares similares
-
TGFβ‐induced FOXS1 controls epithelial–mesenchymal transition and predicts a poor prognosis in liver cancer
por: Bévant, Kevin, et al.
Publicado: (2021) -
TGFβ-induced circLTBP2 predicts a poor prognosis in intrahepatic cholangiocarcinoma and mediates gemcitabine resistance by sponging miR-338-3p
por: Louis, Corentin, et al.
Publicado: (2023) -
A Minimal Subset of Seven Genes Associated with Tumor Hepatocyte Differentiation Predicts a Poor Prognosis in Human Hepatocellular Carcinoma
por: Desoteux, Matthis, et al.
Publicado: (2021) -
DNA Methylation of TGFβ Target Genes: Epigenetic Control of TGFβ Functional Duality in Liver Cancer
por: Bévant, Kevin, et al.
Publicado: (2021) -
Molecular profiling of stroma highlights stratifin as a novel biomarker of poor prognosis in pancreatic ductal adenocarcinoma
por: Robin, Fabien, et al.
Publicado: (2020)